Correction for Ingale et al., Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies
1 Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
2 IAVI Neutralizing Antibody Center at TSRI, La Jolla, California, USA.
3 Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
4 Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA.
5 Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA.
6 Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA IAVI Neutralizing Antibody Center at TSRI, La Jolla, California, USA.